Obliterative bronchiolitis after rituximab administration: a new manifestation of rituximab-associated pulmonary toxicity

Intern Med J. 2012 May;42(5):597-9. doi: 10.1111/j.1445-5994.2012.02778.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal, Murine-Derived / adverse effects*
  • Bronchiolitis Obliterans / diagnostic imaging*
  • Bronchiolitis Obliterans / etiology*
  • Humans
  • Male
  • Radiography
  • Rituximab

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Rituximab